ScholarIQanswers from OpenAlex

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

PaperCitations, authors & open-access status

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer have?

ScholarIQcitation count

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer has 475 citations in the OpenAlex counts ScholarIQ stores.

When was Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer published?

ScholarIQyear

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer has 2017 year in the ScholarIQ index.

What is the open-access status of Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer?

ScholarIQoa status

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer?

ScholarIQdoi

The DOI for Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer is on the source record.

What is the PMID of Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer?

ScholarIQpmid

The PMID for Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer is on the source record.

What is the OpenAlex record for Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer?

ScholarIQopenalex

The OpenAlex for Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial